Valneva, the specialty vaccine company, based in Saint-Herblain, France, has appointed a new Chief Commercial Officer and Management Board member: Dipal Patel took over the newly created role in November.

She brings more than 23 years of experience in the pharmaceutical sector covering commercial strategy, execution, market access and life cycle management. Over her career, she has held roles of increasing responsibilities across multiple countries. Since 2019, Patel has been Global Commercial Head of GSK’s shingles vaccine, leading a global cross-functional team establishing it as a global brand with significant worldwide expansion.